- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High Risk Percutaneous Coronary Interventions in Finland
Total 24 results
-
Hospital Universitario Infanta CristinaUnknownDiabetes Mellitus | Percutaneous Coronary InterventionSpain, Finland
-
University of TurkuCompletedAtrial Fibrillation | Percutaneous Coronary Intervention | Oral AnticoagulationFinland
-
University of TurkuFinnish Foundation for Cardiovascular ResearchUnknownCoronary Artery Disease | Percutaneous Coronary Intervention | Coronary Artery Bypass Grafting | Acute Coronary Syndromes | Young PatientFinland, Italy, Iceland, Sweden
-
The Hospital District of SatakuntaUnknownMyocardial Infarction | Atherosclerosis | Percutaneous Coronary InterventionFinland
-
Boehringer IngelheimCompletedAtrial Fibrillation | Percutaneous Coronary InterventionCanada, United States, Spain, Korea, Republic of, Australia, Germany, Taiwan, Hong Kong, Thailand, United Kingdom, Turkey, Netherlands, Ireland, Hungary, Croatia, Colombia, Israel, Singapore, Italy, New Zealand, Greece, Mexico, Norway, Swed... and more
-
Population Health Research InstituteCompletedST Elevation Myocardial Infarction | Acute Coronary Syndrome | Percutaneous Coronary InterventionCanada, United States, Korea, Republic of, United Kingdom, Spain, New Zealand, France, Greece, Austria, Netherlands, Germany, Finland, Serbia, Czech Republic, Australia, Hungary, Brazil, Belgium, China, Macedonia, The Former Yugoslav...
-
Cogentus PharmaceuticalsTerminatedMyocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary InterventionUnited States, France, Canada, Australia, Poland, Germany, Italy, Mexico, Romania, Slovakia, Hungary, Czech Republic, Chile, Bulgaria, Puerto Rico, Ukraine
-
Turku University HospitalUniversity of TurkuCompleted
-
University of OuluThe Finnish Funding Agency for Technology and Innovation (TEKES)Unknown
-
Turku University HospitalUniversity of Turku; Academy of Finland; Foundation for Paediatric Research,... and other collaboratorsCompletedSubstance-Related Disorders | Depression | Anxiety | Pregnancy, High Risk | Parenting | Maternal-Fetal Relations | Prenatal Care | Fetal Exposure During Pregnancy | Perinatal OutcomeFinland
-
Biosensors Europe SAActive, not recruitingAcute Coronary Syndrome | High Bleeding RiskUnited States, Canada, France, Italy, United Kingdom, Germany, Denmark
-
Memorial Hospital of Rhode IslandNational Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Disease | Hypercholesterolemia | Primary Health Care | Management, RiskUnited States
-
Jazz PharmaceuticalsThe Leukemia and Lymphoma SocietyCompletedHigh Risk Acute Myeloid LeukemiaUnited States, Canada
-
UNICANCERCanadian Cancer Trials Group; GONO GROUPActive, not recruitingColon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2)France, Canada
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingHigh-Risk Neuroblastoma | Patient With Insufficient Response ChemoimmunotherapyFrance, Germany, Israel, Spain, United Kingdom, Belgium, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Denmark, Greece, Lithuania, Slovakia
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
-
BayerActive, not recruitingHot Flashes | Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast CancerSpain, France, Belgium, United Kingdom, Hungary, Israel, Italy, Ireland, Germany, Portugal, Finland, Poland, Romania, Canada, Austria, Kazakhstan
-
AstraZenecaThe Cleveland Clinic; IQVIA RDS Inc.CompletedEligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory Neuroblastoma | High Risk NeuroblastomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, France, Slovakia, Austria, Czechi... and more
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Colombia, ... and more